Dr Bita Louise Matin, DDS | |
1494 Balhan Dr, Concord, CA 94521 | |
(925) 682-2002 | |
(925) 682-6532 |
Full Name | Dr Bita Louise Matin |
---|---|
Gender | Female |
Speciality | Dentist |
Location | 1494 Balhan Dr, Concord, California |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003095951 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
122300000X | Dentist | 35643 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Bita Louise Matin, DDS 1494 Balhan Dr, Concord, CA 94521 Ph: (925) 682-2002 | Dr Bita Louise Matin, DDS 1494 Balhan Dr, Concord, CA 94521 Ph: (925) 682-2002 |
News Archive
The Johns Hopkins Bloomberg School of Public Health today announced that Bloomberg Philanthropies, founded by businessman, philanthropist, World Health Organization Global Ambassador for Noncommunicable Diseases, and three-term mayor of New York City Michael R. Bloomberg, will give $300 million to create the Bloomberg American Health Initiative.
Northwestern Medicine researchers are co-investigators in a breakthrough clinical trial that found transplanted human islets prevent hypoglycemic events and provide excellent glycemic control for patients with Type 1 diabetes with severe hypoglycemia. The results of the multi-center, single arm, phase III study are published in Diabetes Care on Monday, April 18. The research was funded by National Institute of Health grants through the National Institute of Allergy and Infectious Diseases and the National Institute for Diabetes and Digestive and Kidney Disease.
Yale Cancer Center researchers have shown that a tiny genetic variation predicts chances of survival and response to treatment for patients with ovarian cancer.
Due to bioprosthetic valve degeneration, aortic valve-in-valve (ViV) procedures are increasingly performed. There is no data on long-term outcomes after aortic ViV. Our aim was to perform a large-scale assessment of long-term survival and reintervention after aortic ViV.
The U.S. Food and Drug Administration approved Tafinlar (dabrafenib) and Mekinist (trametinib), administered together, for the treatment of anaplastic thyroid cancer (ATC) that cannot be removed by surgery or has spread to other parts of the body (metastatic), and has a type of abnormal gene, BRAF V600E (BRAF V600E mutation-positive).
› Verified 4 days ago
Dr. Hera Zoe Blazer, DDS Dentist Medicare: Medicare Enrolled Practice Location: 3556 Concord Blvd, Concord, CA 94519 Phone: 925-685-4820 Fax: 925-685-4824 | |
Lida Behnam, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 2401 High School Ave, Concord, CA 94520 Phone: 925-685-9749 | |
Dr. Lynn Robert Oakleaf, D.D.S Dentist Medicare: Not Enrolled in Medicare Practice Location: 2951 Salvio St, Concord, CA 94519 Phone: 925-682-2000 | |
Gita Rohanitazangi, Dentist Medicare: Not Enrolled in Medicare Practice Location: 1253 David Ave, Concord, CA 94518 Phone: 925-812-4128 | |
Dr. Dick Mah Hom, DDS Dentist Medicare: Accepting Medicare Assignments Practice Location: 1925 Parkside Dr, Concord, CA 94519 Phone: 925-676-1440 Fax: 925-676-0313 | |
James Bailey Jr., DDS Dentist Medicare: Medicare Enrolled Practice Location: 1851 Sutter St, Concord, CA 94520 Phone: 925-827-2798 |